Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Air toxics regulatory issues facing urban settings

Journal Article · · Environmental Health Perspectives
DOI:https://doi.org/10.2307/3433002· OSTI ID:530608
;  [1]
  1. National Institute of Environmental Health Sciences, Research Triangle Park, NC (United States)
Biomarker research does not exist in isolation. Its usefulness can only be realized when it is translated into prevention strategies to protect public health. In the context of air toxics, these prevention strategies begin with the development of regulatory standards derived from risk assessment schemes. The Clean Air Act Amendments of 1990 list 189 air toxics, including many volatile organics, metals, and pesticides. The National Institute of Environmental Health Sciences (NIEHS), through its affiliation with the National Toxicology Program, has generated toxicity and carcinogenicity data on more than 100 of these air toxics. The NIEHS extramural and intramural research portfolios support a variety of projects that develop and validate biomarkers for use in environmental health science and risk assessment. Biomarkers have a tremendous potential in the areas of regulating air toxics and protecting public health. Risk assessors need data provided by biomarkers of exposure, biomarkers of close/pharmacokinetics, biomarkers of susceptibility or individual variability, and biomarkers of effects. The greatest benefit would be realized if biomarkers could be employed in four areas of primary and secondary prevention. The first is the use of biomarkers to enhance extrapolation of animal data to human exposure situations in establishing risk standards. The second is the use of biomarkers that assess noncancer, as well as cancer, end points. Important health end points include pulmonary dysfunction, immunotoxicity, and neurotoxicity. Third, biomarkers that serve as early warning signs to detect intermediate effects would enhance our ability to design timely and cost-effective intervention strategies. Finally, biomarkers used to evaluate the effectiveness of intervention strategies both in clinical and regulatory settings, would enable us to ensure that programs designed to protect public health do, in fact, achieve the desired outcome. 9 refs., 2 tabs.
Sponsoring Organization:
USDOE
OSTI ID:
530608
Report Number(s):
CONF-9504282--
Journal Information:
Environmental Health Perspectives, Journal Name: Environmental Health Perspectives Journal Issue: Suppl.5 Vol. 104; ISSN 0091-6765; ISSN EVHPAZ
Country of Publication:
United States
Language:
English

Similar Records

Identifying and controlling pulmonary toxicants. Background paper
Technical Report · Mon Jun 01 00:00:00 EDT 1992 · OSTI ID:7302611

EPA priorities for biologic markers research in environmental health
Journal Article · Sat Oct 31 23:00:00 EST 1992 · OSTI ID:7019219

Interpretation of epidemiologic field studies and calculated risk estimates
Conference · Mon Sep 01 00:00:00 EDT 1986 · Am. J. Epidemiol.; (United States) · OSTI ID:6608975